Table III. FGFR4 polymorphism and MYCN amplification status or Risk group.
Genotype | OR (95% CI) | P value | |||
---|---|---|---|---|---|
MYCN amplified | MYCN non-amplified | Unknown | |||
GG | 13 (37%) | 21 (31%) | 11 (46%) | 1.0 | |
AG | 18 (51%) | 42 (63%) | 9 (38%) | 0.5 (0.3-1.2) | 0.1 |
AA | 4 (12%) | 4 (6%) | 4 (16%) | 1.8 (0.5-6.7) | 0.4 |
High Risk | Non-High Risk | Unknown | |||
GG | 24 (39%) | 16 (31%) | 5 (38%) | 1.0 | |
AG | 33 (54%) | 30 (58%) | 6 (46%) | 0.7 (0.3-1.5) | 0.4 |
AA | 4 (7%) | 6 (11%) | 2 (15%) | 0.6 (0.2-2.0) | 0.4 |